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Abstract 
The increasing use of metallic nanoparticles (MNPs) in a wide variety of applications have consequently 
lead to an urgent need to evaluate the impact of these new materials on human health and the 
environment. To date, the potential toxicity of MNPs as well as their interaction mechanisms with cells 
and living organisms have not been fully addressed. In this article, we discuss the different bioanalytical 
strategies that have been used so far with this purpose. We consider different methods aim to evaluate 
cellular uptake and localization in cells and tissues, and in vitro methods for the study of the toxicity 
induced by MNPs considering different toxicity markers and high throughput approaches for the 
identification of specific targets involved in the cell-MNPs interaction. Special strategies related to the 
use of animal models to assess in-vivo toxicity of MNPs are also discussed. 
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1. Introduction 
In the last years, nanoparticles (NPs) have received a great attention for their use and applicability in 
many new consumer products. A recent estimate suggests that more than 1000 NP-containing consumer 
products are currently on the market. In addition, their ability to advance science with novel analytical 
and medical tools also make them relevant to both physical and life sciences [1].  
NPs are generally defined as spheres with a diameter between 1 and 100 nm. This small size 
gives them unique properties, especially because their specific surface area is larger and their reactivity is 
increased or different compared to bulk materials. These specific features are often linked with a potential 
toxicity [2]. Among the different kinds of NPs, metallic nanoparticles (MNPs) are being particularly used 
in many applications. The products and applications of MNPs include electronics, optics, textiles, medical 
applications, cosmetics, food packaging, water treatment technology, fuel cells, catalysts, biosensors and 
agents for environmental remediation [3, 4]. As a result of these applications, exposure of MNPs to the 
environment and humans are becoming increasingly widespread. Consequently, different metals in the 
form of MNPs have gained an increasing access to tissues, cells and biological molecules within the 
human body [5]. Human exposure to MNPs occurs most likely during manufacturing processes, but 
inhalation of MNPs released to the atmosphere, ingestion of water or food containing MNPs and dermal 
exposure from various sources such as body lotions and sunscreen is possible [6].  
 To date, the impact of MNPs exposure to human health and the environment is not fully assessed 
[7]. Research efforts to assess the toxic potential of MNPs have presented some serious and far-reaching 
challenges and there remains an urgent need for well-designed studies that will generate data so that risk 
assessments for MNPs can be conducted [8].  
The chemical composition, shape, size, stability, surface coating, functionalization as well as the purity of 
the MNPs become essential for application purposes but also for their potential toxicity [9]. Particle 
chemistry is especially relevant; depending on their chemistry, NPs can show different cellular uptake 
and ability to catalyze the production of reactive oxygen species, which is directly related with toxicity 
[10]. Many studies have also suggested the importance of shape and crystallographic phase when 
evaluating the toxicity induced by MNPs [3, 11]. The uptake and cellular distribution of NPs are greatly 
influenced by their size. It has been demonstrated that cellular internalization is more pronounced for 
small-sized NPs as compared to equivalent high-sized NPs at the same dose [12]. In addition, small 
MNPs show higher reactivity because of their higher surface area [2]. Aggregation of MNPs mainly 
depends on surface charge, material type and size. The formation of MNPs aggregates affects the degree 
of cell internalization and thus modifies the potential toxic effect [13]. It is also crucial to consider surface 
modification of NPs, either by proteins or ions present in the culture media or when using metals, organic 
molecules or polymers as surface coatings [12, 13, 14]. These modifications can drastically change the 
physicochemical properties of MNPs, including their magnetic, electric, and optical properties as well as 
their chemical reactivity [15].  
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 In order to correlate any toxic reaction with a MNP type, it is indispensable to investigate if the 
nanoparticles are attached to the cell surface or if they enter cells. If NPs are found in cells, their 
localization in different compartments such as endosomes, lysosomes, mitochondria, the nucleus or the 
citosol, may also provide some answers regarding their potential toxicity [16]. It is also of great 
importance the understanding of the complex processes that govern cellular uptake and intracellular fate 
of MNPs [17]. Finally, in vivo studies are also needed to design specific and safe clinical trials to develop 
new strategies for the applied use of MNPs and also to evaluate the risk to the environment [18].   
In this review, we present different analytical and bioanalytical strategies to study the interaction 
of MNPs with cells and living organisms in order to assess their potential toxicity. We start by discussing 
different alternatives to evaluate cellular uptake and localization of MNPs by using atomic techniques and 
imaging approaches. In vitro assays to study the interaction of cells with MNPs are also reviewed 
considering both; those that aim to evaluate specific cellular pathways or cellular responses to MNPs 
exposure and those based on high throughput discovery platform focused on the identification of 
particular targets (genes and/or proteins) involved in the cell-MNPs interaction. Finally, considerations 
about in vivo assays depending on the different animal models that have been used to date are also 
reviewed. 
 
2. Cellular uptake and localization of MNPs 
When studying the interaction of MNPs with living organisms and cells, one of the key aspects is the 
evaluation of the cellular uptake and the localization of the MNPs within the cells and tissues. The 
quantification of MNPs and ions released from NPs is mainly carry out by sensitive analytical techniques 
such as inductively coupled plasma-mass spectrometry (ICP-MS), while the localization, which requires 
spatial resolution analysis, is generally performed by different microscopic techniques. 
2.1. Quantification of NPs and ions released from NPs using spectrometric techniques  
ICP sources are regarded as excellent tools for elemental analysis. Many authors have used techniques 
based on ICP in order to provide a quantitative analysis of the uptake process of MNPs in different 
organisms [19]. ICP combined with mass spectrometric detection (ICP-MS) provides high sensitivity and 
robustness for quantifying the metal composition from a large variety of samples. Christen and Fent used 
an ICP-MS equipped with an octopole reaction system to minimize possible interferences, and confirmed 
that the cytotoxicity induced by Ag-doped SiO2 NPs was caused by Ag ions released from the NPs [7]. 
Other detectors have also been coupled to an ICP source for this purpose. The use of ICP with optical 
emission spectroscopy detection (ICP-OES) has been employed to perform cadmium analysis as an 
indication of the concentration of CdSe/ZnS quantum dots (QDs) NPs in plasma and organs of Daphnia 
magna after 48 h of exposure [20]. The impact of three metal oxide NPs (nonporous SiO2, mesoporous 
SiO2 and anatase TiO2 NPs) on the immune response of mast cells was evaluated using ICP-OES, 
showing that the interaction cell-NPs depended on the chemically modified surface of the NPs [21].   
However, the direct analysis of MNPs using ICP as ionization source present some drawbacks 
due to the limited availability of MNPs commercial standards and the low nebulization efficiency. This 
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technique is able to ionize and atomize spherical NPs in the range of 5-25 nm, in aqueous and organic 
solutions [22]. However, the presence of MNPs aggregates might not be effectively ionized in the plasma, 
which can result in lower recoveries. In these cases of low ionization efficiency, electro-thermal 
vaporization (ETV) should be considered as an alternative sample introduction system because it allows 
for pre-digesting the MNPs [23, 24]. Another problem that has to be considered is the potential 
adsorption of the MNPs on the sample introduction system, which can complicate the quantification of 
MNPs in real samples [25]. Thus, it is important to carry out a previous digestion, using the combination 
of both acids and high temperature  [26], to determine the total metal concentration of the tested element. 
In this way, the concentration of Cd and Se were determined in Arabidopsis thaliana plants exposed to 
CdSe/ZnS QDs. Leaves and roots were thoroughly rinsed with Milli-Q water to remove material that was 
neither adsorbed nor integrated by the plant. The tissues were digested in concentrated nitric acid and 
30% hydrogen peroxide (4:1) for 2 hours using a hot plate [27]. Conventional digestion procedures can be 
very time-consuming so the use of microwaves can minimize the time required for sample treatment. In 
addition, a closed digestion microwave vessel might lower the risk of analyte losses in comparison to 
open digestion procedures. The accumulation of TiO2 NPs was observed in lung tissue of Wistar rats after 
analysis of the levels of Ti by digesting the sample with nitric acid and hydrogen peroxide prior to double 
focusing (DF)-ICP-MS detection [28]. Differences between the bioaccumulation of Ag NPs and Ag 
microparticles in rat brain microvessel vascular endothelial cells (BMVECs) were evaluated by acid 
digestion with nitric acid prior to the analysis with ICP-MS. This study demonstrated that Ag NPs are 
accumulated into cells more easily that microparticles [29].  
Analytical methods based on acid digestions offer the possibility to reduce the matrix effects due 
to the elimination of biological components present in the sample or stabilizing agents employed to avoid 
NPs aggregation. However, this procedure makes impossible to distinguish between metal species (MNPs 
uptaked by the organism and other metal species). An alternative to digestion of solid samples is the use 
of ultrasounds. The use of ultrasound-assisted extraction has been shown as a very promising 
methodology for the extraction of both metal species and MNPs. In addition, the use of ultrasonic energy 
breaks existing MNPs aggregates [30]. However, as in the digestion procedures, alteration of the 
chemical form of MNPs might occur due to the use of basic or acid solutions in the extractant. Using this 
approach, the total Ti concentration was determined in fibroblasts exposed to TiO2 NPs after sonication of 
trypsinized cells in an ultrasonic bath for 30 min [11].   
Other techniques including furnace atomic absorption spectrometry (FAAS), which has been 
used to determine the total Ag content in harvested THP-1 cells prior acid digestion in 69% HNO3 [31], 
or graphite furnace atomic absorption spectrometry (GFAAS) [13] have been used as alternative to ICP-
based techniques. 
Despite the numerous advantages offered by ICP-MS and other atomic techniques, it is 
important to emphasize that this technique by itself is unable to differentiate between metal species 
(MNPs, ions, etc.). Previous treatments such as filtration, centrifugation and sedimentation that allow 
isolation of MNPs from solutions, or otherwise, the use of a separation technique coupled to the ICP-MS, 
are required. The use of separation techniques such as liquid chromatography or field flow fractionation 
coupled to ICP-MS are among the most promising approaches. In this term, size exclusion 
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chromatography (SEC) columns and hydrodynamic chromatography (HDC) have been described in the 
literature as alternatives to separate MNPs of sizes ranging from 10 to 80 nm [32, 33]. Currently, field 
flow fractionation (FFF) is a promising method for size separation of natural and engineered NPs, 
providing a wide dynamic range. Although an ultraviolet (UV) detector is the most common system used 
in combination with a FFF, elemental information can be obtained combining FFF with ICP-MS. One of 
the main advantages of coupling FFF-ICP-MS is not only the possibility for multiple elemental detection, 
but also the higher sensitivity achieved (in the range of ng L-1) as compared to UV detection. To provide 
complementary information, the FFF can also be coupled to a multiangle light scattering (MAL) for 
particle size characterization. The two mainly used FFF principles are the sedimentation (SedFFF) and 
the asymmetric flow field flow fractionation (AF4). SedFFF-ICP-OES has been employed to study size-
based elemental distribution of air particles and MNPs, such as Al, Ti and Fe [34].  
In recent investigations about both the toxicity of TiO2 present in sunscreen products and the 
influence of polymer-coated CdSe/ZnS QDs to Daphnia magna, the on-line coupling of FFF to ICP-MS 
was applied to characterize the particle size as well as the composition of MNPs [20, 35]. In spite of the 
promising results obtained so far, there are still some aspects that require further investigation such as 
problems related to membrane-particle interaction, different behavior of MNPs according to their 
chemical structure, and the influence of eluents during the separation step, which can lead to erroneous 
size information and negatively affect on recovery rates.  
2.2. Determining the stability of MNPs 
The aggregation state of MNPs is a crucial factor for experimentally assessing their toxic activity. In in 
vitro studies, the influence of biological components present in the culture media on MNPs has been 
evaluated in many occasions. It is known that serum proteins, antibiotics, vitamins, electrolytes, etc., may 
interact with MNPs changing their physicochemical properties and aggregation state. While serum 
proteins may absorb onto the MNPs surface changing their size and surface chemistry, the presence of 
electrolytes and the high ionic strength of the culture media may alter their aggregation state. Due to the 
dimensions of the MNPs, the detection and characterization of MNPs is generally performed by 
microscopic techniques. Scanning electron microscopy (SEM), transmission electron microscopy (TEM) 
and atomic force microscopy (AFM) are the most commonly used techniques to visualize MNPs and their 
features including the aggregation state, dispersion, sorption and particle size. Before evaluating the 
toxicity of Ag NPs in different cell lines, Mukherjee et al. determined the Ag NPs stability and its 
possible interaction with the culture media by TEM and SEM [5]. The aggregation state of Ag NPs was 
also studied by Oukarroum et al. where TEM images showed an increase in the diameter of the NPs in all 
the culture media tested for growing two types of green algae [37]. Although TEM images provide useful 
information about the morphology and aggregation state of MNPs, these images might not completely 
represent the morphology of the MNPs under the real experimental conditions because TEM images are 
acquired on dried samples. As an alternative, dynamic light scattering (DLS) can be used combined with 
TEM, thus allowing the analysis of the MNPs to be performed in solution. The characterization of stable 
monodisperse and aggregated Si NPs by TEM and DLS was carried out to study the effect of these MNPs 
on macrophages and fibroblasts. The DLS results demonstrated that the mean hydrodynamic diameter of 
particles increased from 25 nm to 183 nm [2]. The analysis of Au NPs, synthesized in citrate media as 
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reducing agent, by DLS revealed that the surfaces of the NPs were covered by citrate. As it has been 
mentioned above, proteins and other biological molecules may bind to the surface of the MNPs. The 
absorption spectra of Au NPs in solution showed that the NPs were not only covered by citrate, but also 
proteins or lipids were adsorbed onto their surface [37]. 
2.3. Localization of MNPs into cells and living organisms using microscopic techniques 
TEM is also considered an appropriate technique to discriminate between MNPs localized inside cells and 
tissues from those that are only externally attached. Obtaining reliable information about the intracellular 
localization of MNPs is important to establish NP-cell interactions. It is known that smaller NPs can enter 
more easily into cells than larger ones [38], which might explain the higher toxicity of smaller MNPs. 
When it come to design a protocol for electron microscopy, it is very important to select the most suitable 
fixing agent. The most common fixings are aldehydes (glutaraldehyde and formaldehyde) and osmium 
tetroxide. Aldehydes react with amines and amino acids (lysine and arginine), generating cross-linked 
proteins, which preserve cellular structure. However, these fixing agents do not react with most lipids of 
the cellular membrane leading to problems during fixing and processing. For this reason, osmium 
tetroxide is generally used as a secondary fixing since it is able to reacts with unsaturated lipids and with 
some proteins, thus stabilizing the membrane structures and also adding electron density to enhance the 
contrast. Another important aspect is the choice of buffer in which the fixing will be dissolved. It should 
maintain the cell in its physiological state when possible. The most frequently used buffer is PBS. Buffers 
containing amine groups, such as Tris, should not be used because these groups might react with the 
fixing molecule. Typically, samples prepared for TEM analysis have to be dehydrated and embedded in 
resin (overnight with temperature) to allow the cut of ultrathin sections. Allouni et al. developed a 
protocol in which cells were fixed in 1.5% glutaraldehyde and 0.1 M Na-cacodylate buffer (pH 7.4), and 
post fixed in 1% osmium tetraoxide. TEM images revealed that TiO2 NPs were not only attached to the 
surface of the cells, but also they were in vesicles and distributed in the cytoplasm [11]. A mixture of 
glutaraldehyde and formaldehyde is also very commonly used as fixing agent. A fixing solution 
containing 3% paraformaldehyde and 0.5% glutaraldehyde was employed to visualize both the 
localization of SiO2 NPs and Ag doped SiO2 NPs in fibroblast-like fathead minnow cells [17], and Au 
NPs in human lung carcinoma cells A549 [37].  In some cases, resulting blocks embedded in resin are 
incubated in uranyl-acetate (1%-6%) to obtain a higher electron density and image contrast, which is 
especially useful for smaller particulate specimens. However, this stain is not recommended in the 
treatment of specimens that are unstable in acid conditions due to the low pH of solution [7, 11]. 
Ultrahigh resolution microscopy (URI) is a promising technique for studying cells-NPs interactions as it 
allows direct visualization of both cells and MNPs without the need of an elaborate sample preparation 
and without the use of fluorescent tags. In URI the illuminator is connected to the light source by a liquid 
light guide, which allows transport of light without loss of intensity and minimizes the thermal impact on 
living systems. In a recent study, the cellular uptake of TiO2 NPs by fibroblasts was investigated by 
combining scanning (SEM) and transmission (TEM) electron microscopy with URI. For URI analysis, 
cells were washed, fixed in 4% formaldehyde for 15 min at room temperature and finally, a drop of 
mounting media was added to the slides and encased with a cover-slip. URI images showed that TiO2 
NPs appeared to be both up-taken by and attached to the cells, mainly as agglomerates. The 
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discrimination between MNPs attached to the cell from those internalized was performed by changing the 
focus plane in the URI microscope. As shown in Fig. 1, the agglomerates could be easily distinguished 
from other cellular components due to their brightness [11].  
Dark-field microscopy (DFM) is able to provide a panoramic view of non-fluorescent NPs in 
cells since NPs appear as a bright image super imposed on a dark background. Because dark-field 
illumination has a very low background, low signals are sufficient to detect individual non-fluorescent 
NPs. Although there are limited studies on non-fluorescent NPs accumulation at the single-cell level 
using DFM, this technique has been used in studies focused on Au NPs. As in URI, sample preparation is 
very straightforward when using dark field imaging. The accumulation of Au NPs in cells has been 
observed in a time-course experiment.  Cells were seeded on coverslips in 24-well plate and fixed in 4% 
paraformaldehyde for 10 minutes after MNPs exposure [26], and Au NPs embedded inside the cell were 
identified in their aggregated states [17]. 
Another alternative for visualizing MNPs is based on its functionalization with fluorescent 
markers, which allow for using fluorescence microscopy. However, it is important to keep in mind that 
the attachment of a fluorochrome may lead to the alteration of the physicochemical properties of MNPs. 
MNPs can be easily functionalized by using specific fluorochromes, which have their own absorption and 
emission spectra. Fluoresceien isothiocyanate (FITC), ALEXA 488, BODIPY- FL, propidium iodide, 
Mito-Tracker Red and rhodamine, among others, are some of the fluorochromes commonly used in many 
bioapplications. FITC presents maxima absorption in the blue light range of the visible light spectrum 
(approximately at 488 nm). When FITC is irradiated at 488 nm, it fluoresces at 520 nm, emitting a 
greenish-yellow glow. Other fluorochromes such as propidium iodide, ALEXA 488 and BODIPY- FL 
have excitation and emission profiles similar to FITC. On the contrary, rhodamine 123 and Mito-Tracker 
Red fluorochrome are excited by light in the green range and emit in the red wavelengths. Kurepa and co-
workers synthesized Alizarin red S (ARS)-TiO2 NPs conjugates to study the NPs uptake and distribution 
in plants. The covalent surface modification of the MNPs was performed following a straightforward 
protocol in which the MNPs were mixed with an ARS solution. The high surface reactivity of synthesized 
TiO2 NPs (smaller than 20 nm) was very adequate in the formation of ARS-NPs conjugates [38]. 
 
3. In vitro cytotoxicity assays 
Cytotoxicity assays are based on the idea that toxic agents affect basic functions of cells, and thus, their 
toxicity can be evaluated by measuring cellular damage. It is known that the toxic effects of MNPs on a 
cell culture may be different depending on the incubation time and the concentration of MNPs used. 
Many cytotoxic effects are due to the number of internalized MNPs into the cells rather than to the total 
concentration of NPs added to the cell culture media. Generally, the amount of MNPs uptaked by the 
cells differs in several orders of magnitude from the amount of NPs used in the cellular treatment [39]. 
The uptake efficiency does not only depend on the MNPs concentration but also on other properties such 
as MNPs size and shape. Exposure times and concentrations greatly vary from one study to another. 
Concentrations in the order of µg/L or a few mg/L are commonly used, while exposure times ranging 
from 24-96 hours are usually selected [6, 9, 40], although internalization of MNPs has been observed at 
shorter exposure times under certain conditions [15, 41]. 
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When performing a cytotoxicity assay, cell types are generally chosen considering the organ in 
which the studied MNPs are accumulated in organisms. In this term, hepatic cells [42, 43] and 
macrophages [2] are the most commonly used since MNPs tend to accumulate in liver and spleen. Other 
cell types such as fibroblasts, which are the major cellular constituent of fibrous connective tissue, have 
also been used for example to assess the effects of TiO2 NPs released from implant materials [11]. It is 
important to keep in mind that the toxic effects induced by MNPs might depend on the cell line tested and 
these effects may not necessarily have to be the same when exposing other cell lines to the same MNPs 
[44, 5]. In this way, Patra et al. found that citrate-capped Au NPs induced a higher toxicity in human 
carcinoma lung cells as compared to liver carcinoma cells at the same dosage [45]. Actually, the effects 
could even be the opposite as shown by Chen et al., where Se NPs inhibits cellular growth in 
hepatocarcinoma cells but increases cell proliferation when using human fibroblasts [44].  
Below, we describe several common assays that have been applied when evaluating the effect of 
MNPs in different cell lines, most of them involving the use of vital dyes, protease markers, and 
colorimetric, fluorescence, or luminescence detection. 
3.1. Assessment of membrane integrity 
The cell membrane is a thin semi-permeable membrane that surrounds the cytoplasm of a cell and 
constitutes a functional barrier. Its function is to protect the integrity of the cell by controlling the traffic 
into and out of the cell, which is regulated by transporters, receptors and secretion pathways. Since 
cytotoxic compounds often compromise the cell membrane, assessing cell membrane integrity is one of 
the most common ways to measure cell viability and cytotoxic effects. For this purpose, the so-called 
vital dyes, such as trypan blue and propidium iodide, are generally used, which are compounds able to 
freely cross the cell membrane when it has been compromised and stain intracellular components, but are 
excluded from the inside of healthy cells [46]. Alternatively, membrane integrity can be evaluated by 
monitoring the presence in the culture media of substances that are normally sequestered inside healthy 
cells [5]. One commonly measured is lactate dehydrogenase (LDH) [47]. LDH leakage from damaged 
cells can be measured with a coupled enzymatic assay resulting in the conversion of a tetrazolium salt 
into a red formazan product. The intensity of the color produced is proportional to the number of cells 
with compromised plasma membrane [37]. There are several commercially available kits to carry out the 
this assay, which does not involve any kind of sample preparation since the substrate mixture is directly 
added to the culture media and the resulting reaction product (red formazan) is measured 
spectrophotometrically. Using this assay, Hussain et al. showed that LDH leakage for MoO3, Al, Fe3O4, 
MnO2, and W NPs did not produce cytotoxicity up to a concentration of 100 µg/mL in rat liver cells, 
while Ag NPs were highly toxic at those concentrations in the same cells [10]. In the same manner, 
Gerloff et al. showed that only anatase-rutile containing NPs, in contrast to the pure fine TiO2, induced 
cytotoxicity in human intestinal cells [3]. 
3.2. Measurement of cellular metabolic activity 
An early indication of cellular damage is a reduction in metabolic activity. Thus, assays able to measure 
metabolic functions such as ATP levels or mitochondrial activity have been widely used to evaluate the 
toxicity of metallic nanoparticles. One of the most widely used methods is the 3-(4, 5-Dimethyl-2-
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thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay [14, 48], which measures the reducing 
potential of a cell. It is based on the capacity of healthy cells to reduce MTT to formazan by 
mitochondrial reductases. Formazan is a colored compound whose absorbance can be measured 
spectrophotometrically at a wavelength between 500-600 nm. In this approach, cells are incubated with 
MTT (2-10 mg/L) between 4-5 hours and then the formazan crystals are commonly dissolved in dimethyl 
sulfoxide (DMSO) (or other organic solvent) prior colorimetric detection. It is important to consider the 
signal provided by the phenol red usually present in culture media. Thus, it is recommended to either use 
red-phenol free media or to remove the media before dissolving the formazan crystals. The cytotoxicity of 
several MNPs has been evaluated by comparing the absorbance of formazan in control vs. cells exposed 
to MNPs. Christen and Fent showed that human hepatic cells (Huh7) reacted more sensitively to SiO2 
NPs than fibrolast-like fish cells (FHM). Exposure of the two cell lines with SiO2-Ag NPs, containing 1, 5 
and 20% of Ag demonstrated again that Huh7 cells were more sensitive than FHM cells (Fig. 2) [7].  
Yuan et al. used the MTT assay to show how the viability of lung fibroblast exposed to ZnO decreased in 
a dose-dependent manner independently of the particle size [49]. Other close dyes such as 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), 2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) and water soluble tetrazolium 
salts (WSTs) have also been used for the same purpose [3, 6].  
3.3. Evaluation of the oxidative stress 
Oxidative stress is an imbalance of pro-oxidants and antioxidants. It is associated with increased 
production of oxidizing species or a significant decrease in the effectiveness of antioxidant defenses. One 
common way to analyze oxidative stress in cells is by measuring glutathione (GSH) levels. GSH is the 
major intracellular low-molecular-weight thiol that plays a critical role in cellular defense against 
oxidative stress. There are many commercially available GSH detection kits mainly based on colorimetric 
and fluorimetric detection. One key step in this approach is the thorough wash of the cells with PBS to 
remove the excess of dye prior detection. GSH measurement is widely used in toxicological studies [50] 
and it has also been used to evaluate the toxicity of different MNPs. For example, GSH depletion has 
been observed in cells exposed to Ag NPs, although the degree of depletion greatly depended on the cell 
line tested [5]. When cells are exposed to environmental stress they can generate reactive oxygen species 
(ROS), both radical ROS (nitric acid and hydroxide radicals) and non-radical ROS (hydrogen peroxide). 
When the increase of ROS is too high and it overwhelms the antioxidant defense, cells are prone to suffer 
cell damage and even apoptosis. Several studies have linked the increase of the ROS level in cells with 
the exposure to MNPs; thus allowing the use of the ROS level as a cytotoxicity marker. The most widely 
used method to measure the intracellular production of ROS is the dichlorodihydrofluorescein diacetate 
(DCFH-DA) assay [8]. DCFH-DA penetrates the cells, where it is hydrolyzed by unspecific esterases and 
converted into a stable green fluorescent product (DCF) in the presence of oxidative species [53]. DCFH-
DA is prepared in phenol red-free media and used at a final concentration of 10 µM. Cells are incubated 
with this reagent for 15-30 min and then washed twice with phosphate buffer saline (PBS) prior 
fluorimetric detection. It is important to carry out this assay in the dark to avoid fading of the fluorophore. 
Using this approach, Konczol et al. demonstrated that the ROS production observed in alveolar epithelial 
cells increased after 24 h of incubation with Fe3O4 NPs in a concentration-dependent manner. This study 
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also showed that the particle size was not related with the cytotoxicity of these MNPs [51]. Reaction of 
generated ROS with other fluorescent probes such as dihydroethidium (DHE) has also been used [52]. In 
addition, when the ROS production increases, other intracellular events like lipid peroxidation are 
initiated; thus, by measuring these events it is also possible to evaluate the oxidative damage of cells 
exposed to MNPs. Malondialdehyde (MDA) formed from the breakdown of polyunsaturated fatty acids, 
can be used as a convenient index for determining the extent of lipid peroxidation reactions. MDA 
formation can be measured by western blot [53], enzyme-linked immunosorbent assay (ELISA) or by the 
traditional thiobarbituric acid reactive substances (TBARS) assay based on the reaction of MDA with 
thiobarbituric acid reactive susbtances to yield a fluorescent product [41].  After cell lysis, the cell extract 
is mixed with the reaction solution and incubated at 90ºC for 1 h. The product formed is extracted with an 
organic solvent such as butanol and the fluorescence is measured in the organic phase. Addition of 
cadmium chloride to control cells can be used as positive control since it induces lipid peroxidation [52]. 
Passagne et al. used this assay to show how SiO2 NPs affected the production of MDA depending on the 
cell line tested and the particle size. While smaller NPs (20 nm) induced the formation of MDA in 
porcine tubular cells to a larger extent as compared to bigger NPs (100 nm), the effect of both NPs was 
not significantly different when using human kidney cells [52]. 
3.4. Measuring apoptosis induced by MNPs 
As commented before, exposure of cells to MNPs can increase ROS production and lipid peroxidation, 
which ultimately can cause apoptosis. There are several strategies to evaluate the degree of apoptosis 
based on the measurement of different parameters. There are several protein markers of apoptosis 
including Bax, Bcl2, p53 and caspases that can be easily monitorized using Western Blot with the 
appropriate antibodies [8, 55], colorimetric assays [56] or real-time polymerase chain reaction (PCR) [38, 
58]. Apoptosis can also be visualized by studying nuclear morphology, particularly chromosome 
condensation, assessed using nuclear specific dyes such as 4´-6-diamidino-2-phenylindole (DAPI) and 
Hoechst and fluorescence microscopy [54, 55]. However, the general chosen technique to evaluate 
apoptosis is flow cytometry. The most important factor that have to be considered when preparing 
samples for flow cytometry is the density of the cell suspension, which should be kept between 105-107 
cells/mL to prevent the narrow bores of the cytometer and its tubing from clogging. Two common 
methods to evaluate apoptosis by flow cytometry are the measurement of the mitochondrial membrane 
potential and the annexin-V assay. Since mitochondria act as a point of integration for apoptotic signals 
originating from both, the extrinsic and the intrinsic apoptotic pathways [57]; loss of mitochondrial 
membrane potential can be associated with the activation of caspases and the initiation of apoptotic 
cascades [58]. To measure the percentage of cells with depolarized mitochondria, resuspended cells are 
incubated at 37ºC for 10-15 min with a solution of 10 µg/mL JC-1 (5,5´,6,6´-tetrachloro-1,1´,3,3´-
tetraethylbenzimidazolcabocyanine iodide). After incubation, cells are immediately centrifuged to remove 
the supernantant and the cell pellet is resuspended in PBS and then analyzed by flow cytometry. The 
membrane-permeant JC-1 dye exhibits potential-dependent accumulation in mitochondria, indicated by a 
fluorescence emission shift from green (~529 nm) to red (~590 nm). Consequently, mitochondrial 
depolarization is indicated by a decrease in the red/green fluorescence intensity ratio. The potential-
sensitive color shift is due to concentration dependent formation of red fluorescent J-aggregates [54]. 
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Using this method, Chen et al. demonstrated that SeNPs induced apoptosis in melanoma cells through 
mitochondrial-mediated pathways. In this study, de percentage of cells with depolarized mitochondria 
increased from 5.6% (control) to 9.3% when exposing the cells to 20 µM SeNPs, and up to 30.0% when 
using 40 µM SeNPs [56]. 
In apoptotic cells, phosphatidyl serine (PS) is translocated from the inner to the outer leaflet of 
the plasma membrane; thus, PS becomes exposed to the external cellular environment. Annexin V labeled 
with a fluorophore such as FITC, can selectively identify apoptotic cells by binding to the exposed PS on 
the outer leaflet of the membrane. The number of labeled cells can then be quantified by flow cytometry. 
Annexin V-FITC is usually used together with propidium iodide (PI) to differentiate between apoptotic 
and death cells. Cells are resuspended (106cells/mL) in binding buffer (10 mM HEPES/NaOH, pH 7.5 
containing 140 mM NaCl and 2.5 mM CaCl2) and then incubated in the dark with annexin V-FITC and PI 
for 10 min at room temperature [54]. Generally, fluorescence emitted by annexin V-FITC and DNA-
bound PI in each event is detected as green and red fluorescence, respectively. Other fluorophores can 
also be conjugated to annexin-V [44]. This assay is generally used to confirm that the cell death observed 
after exposure to certain MNPs is generally caused by apoptosis [44, 59]. It is important to mention that 
certain fluorochromes may be adsorbed on the surface of MNPs, which may cause fluorescence of the 
NPs, and quenching or enhancement of the fluorescence of fluorochromes, thus altering the results of the 
flow cytometry assay. In addition, cellular internalization or deposition of MNPs may avoid the correct 
binding of the fluorochromes to their target molecules. As an example, the annexin-V assay may gives 
false negatives as a result of NPs deposition on the cellular membrane, which hinder the annexin-V from 
binding to PS. 
 
3.5 Genotoxicity assesment 
The potential DNA damaging properties of MNPs has also been assessed in many cases using the Comet 
and the formamidopyrimidine glycosylase (Fpg)-modified Comet assay [3, 51, 54]. The comet assay 
(also known as single cell gel electrophoresis) is a rapid, sensitive and simple method for detecting DNA 
damage at the level of individual cells [60]. It involves encapsulation of single cells in low melting point 
agarose. Then, cells are lysed to form nucleoids containing supercoiled loops of DNA. Electrophoresis at 
high pH results in DNA structures resembling comets. It is important to reduce the pH after 
electrophoresis to avoid the contribution of alkali-labile sites since they strongly decrease the sensitivity 
of the comet assay. The extent of DNA migration depends directly on the DNA damage present in the 
cells. It should be noted that DNA lesions consisting of strand breaks after treatment with alkali either 
alone or in combination with certain enzymes (endonucleases) increases DNA migration, whereas DNA-
DNA and DNA-protein cross-links result in retarded DNA migration. This is followed by visual analysis 
with staining of DNA with ethidium bromide [54, 61]. Alternative dyes such as propidium iodide, 
Hoechst or DAPI have also been used. The intensity of the comet tail relative to the head reflects the 
number of DNA breaks. Gong et al. used this assay to evaluate the effect of SiO2 NPs of different particle 
size in human keratinocytes showing a significant increase in the comet tail length of cells exposed to 
smaller SiO2 (15 nm), which means an increased DNA damage in a NP size-dependent manner (Fig. 3) 
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[62]. Several studies used a modification of the comet assay in order to specifically evaluate oxidative 
DNA damage. For this purpose, the endonuclease formamido pyrimidine glycosylase (Fpg) is generally 
used for detection of 8-OH guanine, other damaged purines, basic sites (AP sites) and ring-opened N-7 
guanine adducts [63]. This endonuclease is added to the gel and incubated for 30 min at 37ºC in a 
humidified chamber. It is important to prepare this enzyme in a buffer solution containing b-
mercaptoethanol to preserve the enzyme and to take into consideration that the inclusion of sulphydryl 
reagents in the reaction buffer would significantly increase background DNA breakage. Gerloff et al. 
demonstrated that only anatase/rutile TiO2 NPs significantly increased DNA strand breakage while none 
of the anatase TiO2 NPs induced oxidative DNA damage [3]. 
3.6. Use of microscopy to study cellular morphological alterations 
Several studies derived from electron microscopy analyses have reported morphological alterations in the 
cell layer and/or cell shape after exposure to cytotoxic agents. Therefore, it is not surprising that the 
visualization of morphological alterations is considered as a primary index of toxicity. Changes in the 
morphology of lung fibroblasts were examined by SEM after incubation with 20 nm ZnO NPs for 72 
hours. For this analysis, cells were washed with PBS and dehydrated in 35% alcohol for 10 min, followed 
by consecutive addition of ethanol solutions from 40% to 100%. Finally, the samples were dried in 
vacuum before SEM analysis. A very rough cell surface was observed in ZnO NPs treated cells as 
compared with control cells, which have a regular morphology and smooth surface. Moreover, the 
presence of nanosized pores of 20 nm in the plasma membrane indicated that ZnO NPs could have 
entered into the cells, thus affecting the inner structure and inducing apoptosis and/or necrosis [49].  
Unlike SEM or TEM techniques, the use of phase contrast microscopy allowed examining living cells in 
its natural state without the need of previous fixation or dehydration steps. Hussain et al. observed that 
increasing the Ag NPs concentration in culture media led to morphological changes in rat liver cells, 
which started to shrink and became irregular in shape [10]. In the same way, the cellular morphology of 
epithelial carcinoma cells was observed in order to evaluate the cytotoxicity of Fe3O4 NPs with different 
surface functionalizations [14]. For a more exhaustive visualization of the morphological changes, cells 
may be fixed and differentially using the hematoxylin-eosin method. Whereas hematoxylin (blue-purple 
dye) stains nucleic acid, eosin (pink dye) stains proteins nonspecifically. The required protocol for sample 
preparation is very straightforward. In a study of cytotoxicity of Fe NPs, HeLa cells were seeded on the 
glass coverslips in 24-well plate and incubated for 2 h with the NPs. Then, cells were fixed with 4% 
paraformaldehyde and stain with hematoxylin and eosin. In this case, no significant changes in cellular 
morphology was observed after exposure to Fe NPs [30], which could be due to the extremely short 
exposure time selected to carry out the study.  
3.7. High throughput discovery platforms 
In addition to the assays commented before, which are mainly based on target-directed approaches, high 
throughput discovery platforms based on gene and protein expression profiling can provide very useful 
information on the specific mechanisms of interaction of MNPs with cells. Gene expression is the term 
used to describe the transcription of the information contained within the DNA into messenger RNA 
(mRNA) molecules that are then translated into proteins. The study of the kinds and amounts of mRNA 
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produced by a cell under certain conditions, which is directly related to which genes are expressed, 
provides insights into how the cell responds to a particular perturbation. A way to evaluate the expression 
of many genes in a single experiment is by using DNA microarrays. A DNA microarray is a collection of 
microscopic DNA spots immobilized in a solid surface. Each DNA spot contains picomoles of a specific 
DNA sequence, known as reporters (also known as probes or oligos), which can be a short section of a 
gene or other DNA element used to hybridize a cDNA or a cRNA. Probe-target hybridization is usually 
detected and quantified by detection of fluorophore, silver-, or chemiluminescence-labeled targets to 
determine relative abundance of nucleic acid sequences in the target. Hanagata et al [64]. carried out a 
whole genome expression analysis to study the molecular responses of lung epithelial cells to CuO NPs. 
After extraction of the RNA from cells exposed to CuO (or control cells), the RNAs were amplified and 
labeled with fluorescence probes (Cy3 and Cy5). Hybridization of the amplified RNAs with the DNA 
microarray was carried out for 18 h at 65ºC. Then, the microarray was scanned to measure the 
fluorescence intensity of Cy3 and Cy5. The foreground and background median values of each spot were 
obtained from median values of the pixels included in each spot area. The difference between the 
foreground and background values of each spot was established as the signal strength, and only spots with 
signal values > 3 times the noise value were considered valid spots. The results indicated that change of 
gene expression involved in mitogen-activated protein kinases (MAPKs) pathways and cell cycle 
progression in cells exposed to CuO NPs was similar to that in cells exposed to Cu ions [64]. With a 
similar approach Mahmoudi et al. evaluated the toxicity of superparamagnetic iron oxide in different cell 
lines (heart, brain and kidney) [65] and Dua et al. the toxicity indeced by mesoporous silica-NPs, Fe2O3-
NPs and ZnO-NPs in kidney cells [66]. The findings using this approach have to be analyzed by means of 
powerful bioinformatic tools due to the large amount of data obtained. In addition, alternative methods 
such as real time-PCR are also required for further validation of the identified targets. Examining changes 
in protein expression can also be very useful for better understanding the effects of MNPs in cells [67].  
Among all the proteomic approaches available, quantitative strategies are particularly attractive 
since they allow for the identification of differentially expressed proteins in cells exposed to MNPs as 
compared to control cells. Although these approaches are extensively being used in other research areas 
[68], they have been applied to study MNPs toxicity in only a few studies. Yang et al. used two-
dimensional differential gel electrophoresis (2D-DIGE) to identify proteins altered after SiO2-NPs 
exposure. In this study, control and cells exposed to SiO2 were differentially labeled with Cy3 and Cy5 
dyes for comparison on the same gel. The labeling reaction was carried out for 30 min at 4ºC in the dark 
and then quenched with a 50 fold molar excess of free lysine. The internal standard was labeled with Cy2 
dye and use on all gels to aid image matching and cross-gel statistical analysis. The proteomic analysis 
revealed that 16 differentially expressed proteins were induced by SiO2 NPs exposure, and that the 
expression levels of these proteins were associated with the particle size [69]. Jeon et al. also used 2D-
DIGE (two-dimensional difference gel electrophoresis) to analyze the hepatotoxicity induced by TiO2 in 
liver cells, finding 15 altered proteins related to inflammation, apoptosis and antioxidative reaction [70]. 
Alternatives to 2D-DIGE, such as stable isotopic labeling by amino acids in cell culture (SILAC), 
isobaric tags for relative and absolute quantitation (iTRAQ) and label-free methods should also be 
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considered for future studies since they are generally providing better results than gel-based approaches 
[67]. 
 
4. In-vivo assessment of metallic nanoparticles toxicity 
After in vitro toxicity assays and before the pre-clinical studies, in vivo assays aim to evaluate the toxicity 
of MNPs are needed to design specific and safe clinical trials to develop new strategies for the applied use 
of MNPs. The use of this compounds include diagnostic and/or therapeutic purposes although large-scale 
use of MNPs also represent an increasing risk to the health and environment [18, 71]. Several aspects of 
MNPs physicochemical properties are important to design these protocols and of course, the suitable 
biological organism in each case. The target organ in the organism chosen is also one of the major issues 
to test. Therefore it is important to test hepatotoxicity, nephrotoxicity, pulmonary toxicity, spleen toxicity, 
immune system activation, hematological toxicity and oxidative stress among others [72, 73]. Within the 
most important options to consider is the route of NPs administration, especially in higher vertebrates and 
mammalian.  
4.1. Routes of administration in common used animal models 
The acquisition pathway of MNPs by biological systems is determinant, in most cases, to the type and 
extent of potential damage resulting in different organs and tissues. Relevant routes of administration and 
doses in different animal model are discussed below. 
4.1.1. Skin absorption. This route of administration involves not only the active absorption after direct 
application to the skin but also passive uptake of NPs through the skin as, for example, by respiration 
after nebulization in a chamber or directly in the water, for aquatic animals [74]. The zebrafish is a 
genetically-tractable vertebrate model organism commonly used for the in vivo administration and testing 
of MNPs toxicity. Compared to other vertebrate animal models, zebrafish have several benefits. 
Importantly, the housing and maintenance is less expensive what makes it an attractive model for 
preliminary studies of toxicity and/or environmental contamination. Moreover zebrafish model for the 
assessment of toxicity are easily extrapolated to other vertebrates and humans. The short life cycle of this 
aquatic vertebrate makes this model very suitable for the study of embryo viability and genetic 
malformations during the treatment with NPs. Assessment of MNPs toxicity in zebrafish includes 
immune-hystochemical analysis, flow cytometry studies to detect reactive species of oxygen and 
proteomic analysis for well-established stress cellular markers [75]. Eurasian perch, oysters and the 
fruifly share many of the zebrafish characterisitics to make them suitable models for toxicity studies 
although are used less frequently because their genetic is not well known. 
4.1.2. Airways release. Ag and Au NPs in vivo toxicity have been studied in models of sub-chronic 
inhalation trying to have a complete study of toxicity that measure the adsortion, distribution, metabolism 
and excretion (ADME) of the MNPs in vivo in rats [76]. These studies, although not very common, need 
to be done for commercial purposes and for the use of MNPs in humans. The most important parameters 
are the minimum dose for an adverse effect (LOAEL) and the dose without an adverse toxicity effect 
included in the pre-clinical trial (NOAEL). These studies tested daily different doses of, for example, Au 
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NPs in different groups of male and female rats with 6 hours inhalation treatment consecutively during 
three months. Airways, skin and mucosas (oral, nasal and genital) were checked daily and the rats weight 
was monitored once in a week. The analysis before mortem included biochemistry and hematologic 
parameters, nephrotoxicity and lung function. The post-mortem study consisted in multiorganic 
histopathologycal analysis (including broncho-alveolar lavage). Au accumulation in tissue was measured 
by atomic absorption spectrophotometer [76].  
4.1.3. Systemic administration. Commonly used routes for systemic release of MNPs are intra-venous 
(i.v.) and intra-peritoneal (i.p.) injection. The systemic administration of MNPs by these two pathways 
allows the study of their organ distribution after different time points. The organs are extracted from 
injected mice and accumulation of nanoparticles is generally analyzed by ICP-MS and/or by fluorescent 
imaging with confocal microscopy. Interestingly, silica-overcoated magnetic small size (50 nm) 
nanoparticles containing rhodamine B isothiocyanate were recruited to the brain, through the blood brain 
barrier [77], whereas Au NPs with a diameter of 100-250 nm were retained in different tissues and organs 
such as liver, spleen, kidney, or lungs [78]. Hematological and biochemical studies are also performed in 
these animals to test the toxicity of nanoparticles in tissues and blood cells. Other interesting approach 
with systemic administration of nanoparticles is the evaluation of mutagenic potential, chromosomal 
aberrations and genotoxicity for germinal cell viability studies [77, 79]. 
4.1.4. Oral gavage. This route of administration has been studied using Cu NPs from different sizes, after 
gavage of mice through naso-gastric probe. In this model of acute toxicity, the effect of the NPs was 
tested after short exposure to high doses. After determination of the LD50 (lethal doses determination for 
50% of the population), a complete histopathology and hematology study has to be performed to describe 
the ADME parameters in vivo in the animal model. 
Oral toxicity determination is important due to the putative use of nanoparticles with food or oral 
administrated drugs [80, 81]. Moreover, oral uptake of nanoparticles through drinking water pollutants or 
passive uptake from other routes of administration as airways or skin, must been taken into consideration 
to fully address the in vivo toxicity of MNPs [82]. A single administration of NPs is performed in the 
acute exposition model for MNPs toxicity assessment; hence increasing doses of the different NPs to test 
and the control (vehicle) are administrated to the mice to detect the LD50. In an interesting study, Chen, et 
al. tested two sizes of Cu NPs (25 nm and 17 nm), and compared the effect to that of soluble ionic Cu 
after nasogastric probe administration. This study revealed the importance of the size of the NPs for the 
induction of toxicity; larger NPs have small amount of surface in contact with the organism and are, 
therefore potentially less toxic than the smaller nanoparticles or the ionic Cu. Other important conclusion 
from this work is that the study of the different ways of nanoparticles administration is essential to 
understand the differential and specificity of MNPs toxicity induction. As an example, the interaction of 
NPs with H+ in the stomach after oral administration promotes an increase in the release of HCO3-, which 
results in an increase of the pH in the stomach causing renal damage and electrolytic metabolic alterations 
[82]. 
Another important issue after oral administration of NPs is the different outcome depending on 
the use of males or females for toxicity tests.  In this regard, males are more prone to produce H+ in the 
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stomach and therefore they are more susceptible to develop renal damage as compared to females [83]. 
All these considerations remark the importance for designing an adequate in vivo toxicity experimental 
model. Moreover, a deep knowledge of the biology from the selected animal is needed to properly assess 
the extent of the route of administration in the toxicity induced by MNPs [82]. 
4.2. Alternative in vivo models 
Other organisms as invertebrates, which permits the analysis of ADME toxicity parameters, have also 
been used for the in vivo evaluation of MNPs toxicity. An important benefit of these models is the 
avoidance of bioethical committees.  
4.2.1. Invertebrate organisms. In an interesting study, Novak and collaborators proposed a terrestrial 
invertebrate, Porcellio scaber  (Isopoda, Crustacea) to test toxicity of TiO2 NPs orally administrated [84]. 
They hypothesized that the TiO2 nanoparticle toxicity could be due to the high doses, exposition time and 
the ability to distribute within the whole animal body after crossing gut epithelial cells barriers. The route 
of administration by feeding the animal with NPs within the intake food permitted the study of several 
parameters as general health score of the animals. Each individual was independently exposed and the 
feed rate was calculated by the relation between food consumption and weight increase from each animal 
and each day of the treatment. The spreading ability of NPs to the whole organism was evaluated by 
analyzing the membrane integrity of gut epithelial cells by immunohistochemistry [84, 85].  
 The use of environmental contamination biomarker organisms is other interesting approach as a 
model to test MNPs induced toxicity. In this regard, the freshwater crustacean Daphnia magna, has been 
used as a contamination biomarker due to its sensitivity to changes in the ecosystem [86]. Moreover, 
Daphnia magna, is part of the trophic chain base revealing important information about the accumulation 
of toxic effects within the rest of the organisms in the ecosystem [87, 88]. In a recent work Asghari et al. 
evaluated the toxicity of different groups of colloidal Ag NPs under an acute and short-term exposition 
model. They determined the minimum dose of Ag NPs inducing lethality in D. magna after 48 hours 
administration in water containers. The toxicity score was evaluated by lethal doses determination (LD10, 
LD50 and LD90), observation of natation defects and progression of paralysis. They concluded from these 
studies that the toxicity of Ag NPs depends on their nature and the aggregation state [89]. Similar studies 
have been performed by other groups to analyze the effects of silver nanoparticles ingested by D. magna 
[89, 90].  
It is interesting to remark a number of benefits and disadvantages derived from the use of 
invertebrate models to test toxicity induced by MNPs. First, the protocols are technically easier as 
compared to vertebrates and mammals and therefore simplified read-out interpretation. These animals are 
big enough to obtain such amounts of biological samples for histopathologic analysis and other purposes. 
Other important issue is the possibility to obtain high number of individuals to increase statistical 
significances. Conversely, nowadays the short experience in these models could be a disadvantage to their 
use as MNPs testers. Other objection to the use of invertebrates is the lack of mathematical models to 
properly read into the results and to extrapolate to the potential toxicity in humans. The last concern could 
be aggravated due to the low physiological correlation between vertebrates and invertebrates. Hence, the 
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ideal situation for properly test the toxicity of MNPs, would be the use of both types of model animals, 
invertebrates and vertebrates.  
4.2.2. Embryo models. Other important factor to be considered is the potential toxicity of MNPs during 
embryonic development. To address this question, Clancy et al. have developed a model of live chicken 
embryo in which MNPs are administered directly in the blood flow. The use of fluorescent NPs, allowed 
the study of their distribution through the whole body, as well as the aggregation behavior, by 
fluorescence spectroscopy. An interesting observation is that NPs tended to aggregate and accumulate in 
blood vessels from different sizes and in tissues with high angiogenic activity. Similarly to the toxicity 
studies in vertebrates, the toxicity in embryo models depends on the bio-distribution of the MNPs and 
their physicochemical properties: size, electrical charge, surface modifications (chitosan, fluorescent 
particles, etc.) [91, 92].  
 The data obtained from living chicken embryo could be extrapolated to adult animals being 
helpful for the development of toxicity protocols. Moreover, chicken embryo is a bonafide model to set 
up this experimentation as their use is not regulated by ethical committees, thus avoiding legal issues 
[92].   
4.2.3. Procariotic organisms. A new biological model using procariotic organisms has been recently 
proposed for MNPs toxicity studies. This model is based on the use of bacteria able to produce 
bioluminescence. Bioluminescence intensity is directly related to cellular metabolism and this correlation 
is used to address the toxicity of the NPs. A decrease in metabolic activity induced by MNPs exposure, 
would result in a decrease in the bioluminescence intensity, which would indicate an increase MNPs 
induced toxicity. The use of bacteria with these characteristics represent a new method to address the 
toxicity of different MNPs in a short time period by analyzing fluctuations of light emission [93]. This 
characteristic of luminous bacteria has been used in promising toxicity studies for Au nanoparticles and 
carbon nanotubes in just 15-minute assays [94]. The results obtained with the luminous bacteria were 
comparable to those obtained with other conventional approaches used to evaluate MNPs induced toxicity 
[95]. 
 
5. Conclusions 
The different alternatives used to date to evaluate the potential toxicity of MNPs using both in vitro and 
in vivo assays has been presented. Although there are an increasing number of articles aiming to assess 
the toxicity of MNPs, there is still an urgent need for standardized protocols allowing for a systematic 
study of the toxicity induced by a particular type of MNPs. As it has been shown, not only the 
concentration and the exposure times are parameters that have to be considered when assessing the 
toxicity of MNPs, but also the stability, particle size, shape and the aggregation state are crucial factors. 
Moreover, when using in vitro models, it has been proved that the behavior may be radically different 
depending on the cell line tested. As for the in vivo models, it has also been shown the importance of 
choosing not only the correct animal model but also the appropriate route of administration, since the 
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toxic response can greatly vary. In addition, it is important to mention that although general toxicity 
assays have been shown to be very useful to evaluate MNPs-induced toxicity, approaches focused on the 
identification of specific targets (genes and/or proteins) may help not only to better understand the 
interaction mechanisms of cells and organisms with MNPs, but also to design novel non-toxic MNPs. 
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Figure Captions 
Fig. 1. URI images of L929 fibroblasts at 100x magnification after 24 h exposure to 0.5 mg/L of TiO2 
NPs. Bright spots are nanoparticles either internalized or attached to the membrane. (A) Control cells. (B) 
Rutile, 40 nm. (C) Rutile and anatase mixture, < 100 nm (D) Anatase, 10 nm. White arrows (C) show 
agglomerates that appear to be attached to the cell membrane; red arrows point at agglomerates inside the 
cells (Reproduced with permission of Elsevier). 
Fig. 2. Cytotoxicity of nanoparticles. Huh7 (left) and FHM (right) cells were treated for 24 h with 
different concentrations of SiO2-NPs (blue dots); SiO2-1% Ag-NPs (green squares), SiO2-5% Ag-NPs 
(black triangle); and SiO2-20% Ag-NPs (red triangle) followed by assessing cell viability by MTT assay. 
Shown are the results of three independent experiments. (Reproduced with permission of Elsevier). 
Fig. 3. The effects of exposure to 15, 30, 100 nm or micro-sized SiO2 particles on DNA damage in HaCat 
(human keratinocytes) cells. Representative images and quantitative analysis of tail length or tail DNA 
percentage of comet in HaCaT cells. Values shown were the mean from 300 randomly selected comet 
images of each sample. (Reproduced with permission of Springer). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
